With a new cancer case diagnosed every 15 seconds in the United States and the global burden of the disease rising, Stanford Medicine has begun charting a bold course to better understand, prevent and treat the disease.
“At the heart of our vision is a deep integration of research and clinical practice — seeing them not as isolated functions but as essential parts of a virtuous cycle,” said Lloyd Minor, MD, the Carl and Elizabeth Naumann Professor for the Dean of the School of Medicine and vice president for medical affairs at Stanford University. “We want to develop an engine of cancer innovation where lab-based discoveries rapidly reach patients and clinical experiences immediately inform research.”
This transformative undertaking will integrate expertise from across the university to advance cancer research, technology and patient-centered care. As part of this strategic initiative, Stanford Medicine has begun exploring the development of an integrated cancer research and clinical care center in Redwood City. Co-locating these facilities would accelerate cutting-edge research and care while also supporting and enhancing Stanford Medicine’s entire cancer-focused network, from Palo Alto to the South Bay and East Bay.
“We are studying the feasibility of a cancer center that would go far beyond simply increasing patient capacity,” said David Entwistle, president and CEO of Stanford Health Care. “Our vision is to build a hub for clinical trials across our network, to accelerate innovation from bench to bedside, and to develop a new model for delivering a patient-centered experience, from prevention to survivorship.”
“This cancer center would bring the full breadth of Stanford’s expertise to bear on cancer,” said Paul King, CEO of Stanford Medicine Children’s Health. “It would help us deliver on our promise to advance complex cancer care and ensure more patients have access to it.”
Stanford Medicine is welcoming the Stanford community to an initial series of open houses, with more engagement opportunities in the future. All faculty, students and staff are invited to participate and connect.
- Open House 1: Wednesday, February 25, in Berg Hall (3-4 p.m.)
- Open House 2: Tuesday, March 3, in Traitel (1-2 p.m.)
- Open House 3: Thursday, March 5, in Assembly Hall (1-2 p.m.)
- Open House 4: Thursday, March 12, in Munger Graduate Residences (1-2 p.m.)
Those wishing to attend in person can register here.
Those unable to attend in person can learn more about the project by reading about Stanford’s vision in Cancer Innovation and Care in this issue of Stanford Medicine magazine.
